Crospon spins out transdermal patch
Crospon has spun out its transdermal controlled release patch into a distinct company, two years after it licensed the system from HP, using funding from a pharma firm to further its development.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs